SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-038370
Filing Date
2014-05-14
Accepted
2014-05-14 08:30:21
Documents
4
Period of Report
2014-05-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-12733_18k.htm 8-K 26133
2 EX-99.1 a14-12733_1ex99d1.htm EX-99.1 20910
3 GRAPHIC g127331mmi001.jpg GRAPHIC 2840
4 GRAPHIC g127331mmi002.jpg GRAPHIC 2839
  Complete submission text file 0001104659-14-038370.txt   56432
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 14839292
SIC: 2835 In Vitro & In Vivo Diagnostic Substances